AI-generated summary
The authors studied human gingival fibroblast cells exposed to a Porphyromonas gingivalis-derived inflammatory challenge, then treated with 660 nm and 970 nm lasers at several doses. They report no change in cell viability and lower expression of inflammatory genes (IFN-γ, IL-6, TNF-α) with laser treatment in the inflammatory model. This is a cell study, not a study in people.
- Who or what was studied
- Human gingival fibroblast cells (HGF1-PI1) in culture; no human participants
- Wavelengths
- 660, 970 nm
- Limits stated in the abstract
- The study used cultured cells rather than people or tissue, and the abstract does not describe clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 970 nm
- Power
- 50 mW, 200 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Inflammation, Laser, Reactive oxygen species, Oxidative stress, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.